| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥142.23B | ¥124.77B | +14.0% |
| Cost of Sales | ¥122.11B | ¥105.72B | +15.5% |
| Gross Profit | ¥20.12B | ¥19.05B | +5.6% |
| SG&A Expenses | ¥12.94B | ¥12.95B | -0.1% |
| Operating Income | ¥7.18B | ¥6.10B | +17.8% |
| Non-operating Income | ¥394M | ¥300M | +31.3% |
| Non-operating Expenses | ¥319M | ¥176M | +81.2% |
| Ordinary Income | ¥7.26B | ¥6.22B | +16.7% |
| Profit Before Tax | ¥7.14B | ¥5.00B | +42.8% |
| Income Tax Expense | ¥2.98B | ¥2.67B | +11.7% |
| Net Income | ¥4.16B | ¥2.33B | +78.3% |
| Net Income Attributable to Owners | ¥3.55B | ¥1.21B | +192.9% |
| Total Comprehensive Income | ¥4.17B | ¥2.84B | +47.0% |
| Depreciation & Amortization | ¥2.63B | ¥1.65B | +59.6% |
| Interest Expense | ¥177M | ¥97M | +82.5% |
| Basic EPS | ¥94.51 | ¥32.43 | +191.4% |
| Dividend Per Share | ¥17.00 | ¥17.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥56.79B | ¥60.35B | ¥-3.56B |
| Cash and Deposits | ¥18.30B | ¥26.73B | ¥-8.42B |
| Accounts Receivable | ¥26.18B | ¥21.38B | +¥4.80B |
| Inventories | ¥5.06B | ¥4.50B | +¥556M |
| Non-current Assets | ¥95.58B | ¥99.32B | ¥-3.74B |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥6.19B | ¥477M | +¥5.71B |
| Investing Cash Flow | ¥-1.02B | ¥265M | ¥-1.28B |
| Financing Cash Flow | ¥-13.68B | ¥-6.20B | ¥-7.49B |
| Free Cash Flow | ¥5.17B | - | - |
| Item | Value |
|---|---|
| Net Profit Margin | 2.5% |
| Gross Profit Margin | 14.1% |
| Current Ratio | 74.6% |
| Quick Ratio | 68.0% |
| Debt-to-Equity Ratio | 1.71x |
| Interest Coverage Ratio | 40.58x |
| EBITDA Margin | 6.9% |
| Effective Tax Rate | 41.7% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +14.0% |
| Operating Income YoY Change | +17.8% |
| Ordinary Income YoY Change | +16.7% |
| Net Income Attributable to Owners YoY Change | +192.7% |
| Total Comprehensive Income YoY Change | +47.0% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 38.90M shares |
| Treasury Stock | 1.38M shares |
| Average Shares Outstanding | 37.53M shares |
| Book Value Per Share | ¥1,500.58 |
| EBITDA | ¥9.81B |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥17.00 |
| Year-End Dividend | ¥17.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| HealthInsurancePharmacy | ¥86.81B | ¥4.05B |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥280.00B |
| Operating Income Forecast | ¥15.50B |
| Ordinary Income Forecast | ¥15.60B |
| Net Income Attributable to Owners Forecast | ¥7.00B |
| Basic EPS Forecast | ¥186.51 |
| Dividend Per Share Forecast | ¥23.00 |
| Property, Plant & Equipment | ¥17.80B | ¥18.14B | ¥-340M |
| Intangible Assets | ¥67.16B | ¥70.34B | ¥-3.18B |
| Goodwill | ¥37.29B | ¥39.40B | ¥-2.10B |
| Investment Securities | ¥155M | ¥143M | +¥12M |
| Total Assets | ¥152.37B | ¥159.67B | ¥-7.30B |
| Current Liabilities | ¥76.10B | ¥74.20B | +¥1.90B |
| Accounts Payable | ¥34.42B | ¥30.71B | +¥3.70B |
| Short-term Loans | ¥14.40B | ¥13.50B | +¥900M |
| Non-current Liabilities | ¥19.97B | ¥23.33B | ¥-3.36B |
| Long-term Loans | ¥15.33B | ¥19.20B | ¥-3.87B |
| Total Liabilities | ¥96.07B | ¥97.53B | ¥-1.46B |
| Total Equity | ¥56.30B | ¥62.14B | ¥-5.84B |
| Capital Stock | ¥5.79B | ¥5.79B | ¥0 |
| Capital Surplus | ¥5.73B | ¥11.30B | ¥-5.57B |
| Retained Earnings | ¥44.89B | ¥41.99B | +¥2.90B |
| Treasury Stock | ¥-2.06B | ¥-1.96B | ¥-99M |
| Owners' Equity | ¥54.36B | ¥57.12B | ¥-2.76B |
| Working Capital | ¥-19.31B | - | - |